🔎 Trials Near Me

Akèy › Maladi selil fòs › Indiana › Indianapolis

Etid klinik pou Maladi selil fòs nan Indianapolis, IN

5 etid pou Maladi selil fòs ap chèche patisipan nan sit nan ak bò kote Indianapolis (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study to Investigate the Effect of Mitapivat on Transfusion Burden in Subjects With Sickle Cell Disease (SCD)

Ap rekriteFaz 3
  • Indiana Hemophilia & Thrombosis Center, Indianapolis
Laj 12 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07656415

A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)

Ap rekriteFaz 1
  • Innovative Hematology - Indiana Hemophilia & Thrombosis Center, Indianapolis
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT07187973

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

Ap rekriteEtid obsèvasyon
  • Indiana Hemophilia and Thrombosis Center, Indianapolis
Tout laj · Tout sèks · Mizajou Aug 17, 2026 · NCT04398628

The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease

Ap rekriteFaz 3
  • Indiana University Health Riley Hospital for Children- Site Number : 8400056, Indianapolis
Laj 10 a 65 · Tout sèks · Mizajou Jul 29, 2026 · NCT06975865

Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease

Ap rekriteEtid obsèvasyon
  • Riley Children's Hospital (MRD-HCT), Indianapolis
  • Riley's Children Hospital (NT-DMT), Indianapolis
Laj 3 a 20 · Tout sèks · Mizajou Jun 4, 2026 · NCT06941389

Etid Maladi selil fòs nan lòt vil

Lòt etid nan Indianapolis

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.